Themis Medicare Limited (NSE:THEMISMED)
India · Delayed Price · Currency is INR 117.53
-4.44 (-3.64%)
Sep 24, 2026, 3:29 PM IST
Themis Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,316 | 3,422 | 4,055 | 3,818 | 3,543 | 3,946 | |
Revenue Growth | -12.75% | -15.60% | 6.22% | 7.74% | -10.21% | 71.07% |
Cost of Revenue | 1,351 | 1,319 | 1,343 | 1,389 | 1,209 | 1,509 |
Gross Profit | 1,966 | 2,104 | 2,712 | 2,429 | 2,334 | 2,437 |
Selling, General & Admin | 908.5 | 1,086 | 1,145 | 997.86 | 781.03 | 610.08 |
Other Operating Expenses | 1,477 | 1,014 | 1,076 | 915.99 | 878.76 | 870.91 |
Operating Expenses | 2,488 | 2,203 | 2,321 | 2,036 | 1,765 | 1,576 |
Operating Income | -522.56 | -99.28 | 391.2 | 392.59 | 569.56 | 861.55 |
Interest Expense | -111.96 | -88.94 | -84.92 | -76.28 | -79.9 | -65.37 |
Interest & Investment Income | - | 19.65 | 15.48 | 24.45 | 47.52 | 37.19 |
Earnings From Equity Investments | 167.75 | 140.48 | 59.25 | 188.05 | 136.18 | 113.4 |
Currency Exchange Gain (Loss) | - | 23.42 | 15 | 16.72 | 32.27 | 15.24 |
Other Non Operating Income (Expenses) | 91.79 | 32.41 | 0.75 | -11.11 | 19.51 | -9.39 |
EBT Excluding Unusual Items | -374.98 | 27.74 | 396.75 | 534.43 | 725.15 | 952.62 |
Gain (Loss) on Sale of Investments | 929.53 | 0.19 | - | - | - | - |
Other Unusual Items | -8.65 | -8.65 | - | - | - | - |
Pretax Income | 545.9 | 19.28 | 396.75 | 534.43 | 725.15 | 952.62 |
Income Tax Expense | 146.15 | 7.85 | 98.42 | 99.2 | 156.14 | 223.81 |
Earnings From Continuing Operations | 399.75 | 11.44 | 298.33 | 435.24 | 569.01 | 728.81 |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income | 399.75 | 11.44 | 298.33 | 435.24 | 569.01 | 728.81 |
Net Income to Common | 399.75 | 11.44 | 298.33 | 435.24 | 569.01 | 728.81 |
Net Income Growth | - | -96.17% | -31.46% | -23.51% | -21.93% | 104.13% |
Shares Outstanding (Basic) | 95 | 92 | 92 | 92 | 92 | 92 |
Shares Outstanding (Diluted) | 95 | 92 | 92 | 92 | 92 | 92 |
Shares Change | 3.42% | -0.01% | 0.01% | 0.03% | 0.01% | 0.28% |
EPS (Basic) | 4.20 | 0.12 | 3.24 | 4.73 | 6.18 | 7.92 |
EPS (Diluted) | 4.20 | 0.12 | 3.24 | 4.72 | 6.17 | 7.91 |
EPS Growth | - | -96.30% | -31.36% | -23.50% | -21.97% | 103.58% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -81.36 | 192.84 | 36.76 | -126.55 | 137.67 |
Free Cash Flow Per Share | - | -0.88 | 2.09 | 0.40 | -1.37 | 1.49 |
Dividend Per Share | - | 0.500 | 0.500 | 0.500 | 0.500 | 0.500 |
Dividend Growth | - | 0% | 0% | 0% | 0% | 16.28% |
Gross Margin | 59.27% | 61.47% | 66.88% | 63.62% | 65.88% | 61.77% |
Operating Margin | -15.76% | -2.90% | 9.65% | 10.28% | 16.07% | 21.83% |
Profit Margin | 12.05% | 0.33% | 7.36% | 11.40% | 16.06% | 18.47% |
Free Cash Flow Margin | - | -2.38% | 4.75% | 0.96% | -3.57% | 3.49% |
EBITDA | -418.37 | 3.93 | 490.48 | 515.05 | 666.88 | 947.1 |
EBITDA Margin | -12.62% | 0.11% | 12.10% | 13.49% | 18.82% | 24.00% |
D&A For EBITDA | 104.19 | 103.21 | 99.29 | 122.46 | 97.32 | 85.55 |
EBIT | -522.56 | -99.28 | 391.2 | 392.59 | 569.56 | 861.55 |
EBIT Margin | -15.76% | -2.90% | 9.65% | 10.28% | 16.07% | 21.83% |
Effective Tax Rate | 26.77% | 40.69% | 24.81% | 18.56% | 21.53% | 23.49% |
Revenue as Reported | 3,408 | 3,516 | 4,102 | 3,865 | 3,658 | 4,012 |
Advertising Expenses | - | 116.55 | 147.12 | 152.07 | 101.5 | 80.56 |